THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Russell Investments Group, Ltd.'s Holding History (CIK: 0001692234)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 4,048 Value ($000) $76 Avg Close $16.59 Range $13.50 - $20.33

Q3 2025

Shares 5,062 Value ($000) $74 Avg Close $12.64 Range $10.82 - $14.87

Q2 2025

Shares 42,491 Value ($000) $469 Avg Close $9.72 Range $7.90 - $11.82

Q1 2025

Shares 48,059 Value ($000) $429 Avg Close $9.31 Range $8.35 - $10.90

Q4 2024

Shares 21,990 Value ($000) $207 Avg Close $9.10 Range $7.88 - $10.26

Q3 2024

Shares 47,098 Value ($000) $380 Avg Close $8.66 Range $7.44 - $10.42

Q2 2024

Shares 50,518 Value ($000) $428 Avg Close $9.03 Range $8.13 - $10.44

Q1 2024

Shares 45,114 Value ($000) $405 Avg Close $9.27 Range $8.21 - $11.71

Q4 2023

Shares 28,979 Value ($000) $326 Avg Close $10.06 Range $8.52 - $11.57

Q3 2023

Shares 46,503 Value ($000) $401 Avg Close $9.65 Range $8.25 - $10.59

Q2 2023

Shares 53,618 Value ($000) $555 Avg Close $11.04 Range $9.98 - $12.03

Q1 2023

Shares 72,854 Value ($000) $790 Avg Close $10.57 Range $9.25 - $11.52

Q4 2022

Shares 72,771 Value ($000) $816 Avg Close $10.51 Range $9.56 - $11.83

Q3 2022

Shares 58,970 Value ($000) $596 Avg Close $9.37 Range $7.53 - $11.00

Q2 2022

Shares 66,161 Value ($000) $598 Avg Close $9.21 Range $8.15 - $10.52

Q1 2022

Shares 71,245 Value ($000) $680 Avg Close $9.80 Range $7.71 - $13.17

Q4 2021

Shares 112,200 Value ($000) $1,238 Avg Close $8.72 Range $7.30 - $11.24

Q3 2021

Shares 67,980 Value ($000) $501 Avg Close $11.19 Range $6.10 - $15.01

Q2 2021

Shares 81,994 Value ($000) $1,190 Avg Close $18.78 Range $14.46 - $22.74

Q1 2021

Shares 87,122 Value ($000) $1,776 Avg Close $19.01 Range $16.46 - $21.21

Q4 2020

Shares 103,228 Value ($000) $1,833 Avg Close $17.95 Range $14.48 - $20.53

Q3 2020

Shares 113,165 Value ($000) $1,672 Avg Close $18.73 Range $14.62 - $22.82

Q2 2020

Shares 96,172 Value ($000) $2,016 Avg Close $25.69 Range $20.17 - $31.35

Q1 2020

Shares 82,368 Value ($000) $1,903 Avg Close $25.03 Range $16.86 - $31.54

Q4 2019

Shares 9,400 Value ($000) $243 Avg Close $19.43 Range $15.72 - $26.47

Q3 2017

Shares 18,508 Value ($000) $634 Avg Close $32.70 Range $23.15 - $42.61

Q2 2017

Shares 21,465 Value ($000) $855 Avg Close $38.45 Range $34.85 - $43.44

Q1 2017

Shares 14,688 Value ($000) $541 Avg Close $31.95 Range $27.80 - $37.18

Q4 2016

Shares 14,688 Value ($000) $464 Avg Close $31.02 Range $24.54 - $38.92

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	4,048	$76	$16.59	$13.50 - $20.33
Q3 2025	5,062	$74	$12.64	$10.82 - $14.87
Q2 2025	42,491	$469	$9.72	$7.90 - $11.82
Q1 2025	48,059	$429	$9.31	$8.35 - $10.90
Q4 2024	21,990	$207	$9.10	$7.88 - $10.26
Q3 2024	47,098	$380	$8.66	$7.44 - $10.42
Q2 2024	50,518	$428	$9.03	$8.13 - $10.44
Q1 2024	45,114	$405	$9.27	$8.21 - $11.71
Q4 2023	28,979	$326	$10.06	$8.52 - $11.57
Q3 2023	46,503	$401	$9.65	$8.25 - $10.59
Q2 2023	53,618	$555	$11.04	$9.98 - $12.03
Q1 2023	72,854	$790	$10.57	$9.25 - $11.52
Q4 2022	72,771	$816	$10.51	$9.56 - $11.83
Q3 2022	58,970	$596	$9.37	$7.53 - $11.00
Q2 2022	66,161	$598	$9.21	$8.15 - $10.52
Q1 2022	71,245	$680	$9.80	$7.71 - $13.17
Q4 2021	112,200	$1,238	$8.72	$7.30 - $11.24
Q3 2021	67,980	$501	$11.19	$6.10 - $15.01
Q2 2021	81,994	$1,190	$18.78	$14.46 - $22.74
Q1 2021	87,122	$1,776	$19.01	$16.46 - $21.21
Q4 2020	103,228	$1,833	$17.95	$14.48 - $20.53
Q3 2020	113,165	$1,672	$18.73	$14.62 - $22.82
Q2 2020	96,172	$2,016	$25.69	$20.17 - $31.35
Q1 2020	82,368	$1,903	$25.03	$16.86 - $31.54
Q4 2019	9,400	$243	$19.43	$15.72 - $26.47
Q3 2017	18,508	$634	$32.70	$23.15 - $42.61
Q2 2017	21,465	$855	$38.45	$34.85 - $43.44
Q1 2017	14,688	$541	$31.95	$27.80 - $37.18
Q4 2016	14,688	$464	$31.02	$24.54 - $38.92